Risperidone
Also known as: Risperdal®
Use
Therapeutic drug management
Special Instructions
It is important to collect trough levels, as they are most reproducible for therapeutic monitoring. The sample should be collected in a red-top or green-top tube, and separated serum or plasma should be transferred to a plastic transport tube. Note that gel-barrier tubes are not recommended for this test.
Limitations
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration (FDA). Therefore, results should be interpreted in conjunction with clinical findings and other clinical laboratory data. Interferences from circulating drugs, metabolites, or other compounds can affect test accuracy. The test does not replace therapeutic drug monitoring or comprehensive clinical evaluation as essential elements of patient care.
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 55157-2
- 9393-0
- 9383-1
- 9394-8
Result Turnaround Time
4-6 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3 mL
Minimum Volume
0.6 mL
Container
Red-top (no additive) tube or green-top (heparin) tube; gel-barrier tubes not recommended
Collection Instructions
Transfer separated serum or plasma to a plastic transport tube. Trough levels are most reproducible.
Storage Instructions
Submission/transport (<3 days): Room temperature. For storage beyond three days, specimen should be refrigerated or frozen.
Other tests from different labs that may be relevant